Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Cefazolin penetration into hepatic cyst fluid during aspiration sclerotherapy
NL-OMON41169Active, not recruiting
- Sponsor
- Radboud University Medical Center
- Start
- Feb 2015
- Modality
- Reversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of cefazolin in hepatic cyst, sponsored by Radboud University Medical Center. Started Feb 2015; status: active, not recruiting.
02
Drugs
cefazolin
03
Conditions
hepatic cyst
Beyond the preview
Go deeper on NL-OMON41169.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON41169.